We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
Robert Shin, MD, FANA, FAAN
Enrique Alvarez, MD, PhD
Jiwon Oh, MD, PhD, FRCPC
ATTR Amyloidosis: Familial Vs Wild-Type
Noel Dasgupta, MD, FACC
Heads Up: It Might Be ATTRv Polyneuropathy – A Microlearning Course on Diagnosis and Treatment
John Berk, MD
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
The Multiple Faces of ATTRv-PN
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
ATTRv-PN: A Complicated Disease With a Poor Prognosis
Diagnosing ATTRv-PN: What's in Your Toolbox?
ATTRv-PN: A Family Affair?
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Shh…Gene-Silencing Therapies for ATTRv-PN
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
New Frontiers in Optimizing Patient Outcomes in Multiple Sclerosis: Strategies for Early Intervention to Address Progression Independent of Relapse
Stephen Krieger, MD
Tirisham Gyang, MD
Augusto Miravalle, MD, FAAN
5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
W. Brian Gibler, MD, FACEP, FACC, FAHA
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Adrian R. Parry-Jones, FRCP, PhD
While Antiplatelets Are Good…They Aren’t for Everyone
Valeria Caso, MD, PhD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education